University Hospital Virgen Macarena
Welcome,         Profile    Billing    Logout  
 5 Trials 
12 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Cortés, Luis F López
INTENSE, NCT05394298: Short vs Long of Usual Treatment for Non Complicated Enterococcal Bacteremia

Recruiting
4
284
Europe
Short-treatment of any active antibiotic regimen 7 days of any active antibiotic treatment for uncomplicated enterococcal bacteremia., 7 days of active antibiotics, Long-treatment of any active antibiotic regimen 14 days of any active antibiotic treatment for uncomplicated enterococcal bacteremia., 14 days of active antibiotics
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla, Spanish Network for Research in Infectious Diseases, Spanish Clinical Research Network - SCReN
Enterococcal Bacteremia
07/24
12/24
DOBLEI, NCT06423898: Ampicillin and Ceftriaxone for the Treatment of Enterococcus Faecalis Infective Endocarditis.

Not yet recruiting
4
284
Europe
Experimental regimen, Control regimen
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla, Spanish Clinical Research Network - SCReN
Endocarditis, Infective
07/27
12/28
SHORTEN2, NCT05210439 / 2021-003847-10: Efficacy and Safety of 7 Versus 14 Days of Antibiotic Treatment for Pseudomonas Aeruginosa Bacteraemia

Recruiting
4
306
Europe
Short-treatment of any active antibiotic regimen, Any active antibiotic with treatment with proven in vitro activity from a pre-stablished list of antibiotics included, Long-treatment of any active antibiotic regimen, Any active antibiotic with treatment with proven in vitro activity a pre-stablished list of antibiotics included
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla, Spanish Clinical Research Network - SCReN, CIBER (Infectious diseases)
Bloodstream Infection
06/25
09/25
VOLITION, NCT05917509: A Study to Evaluate the Efficacy, Safety, Participant Choice and Preference of an Oral Once-daily Regimen or a Long-acting Injectable Regimen Every Two Months for Treatment of Human Immunodeficiency Virus (HIV-1) in Adults Who Have Not Previously Taken Antiretroviral Therapy

Active, not recruiting
3
171
Europe, Canada, US, RoW
DTG/3TC, Dovato, Cabotegravir (CAB) LA, Vocabria, Rilpivirine (RPV) LA, Rekambys
ViiV Healthcare, GlaxoSmithKline, PPD DEVELOPMENT, LP
HIV Infections
10/25
10/26
CINNAMON, NCT06039579: Proof of Concept Treatment Study of Orally Administered VH4004280 or VH4011499 in HIV-1 Infected Adults

Completed
2
44
Europe, Canada, US, RoW
VH4004280, VH4011499, VH4004280 Matching Placebo, VH4011499 Matching Placebo
ViiV Healthcare
HIV Infections
06/24
06/24
Cortes, Luis Eduardo Lopez
INTENSE, NCT05394298: Short vs Long of Usual Treatment for Non Complicated Enterococcal Bacteremia

Recruiting
4
284
Europe
Short-treatment of any active antibiotic regimen 7 days of any active antibiotic treatment for uncomplicated enterococcal bacteremia., 7 days of active antibiotics, Long-treatment of any active antibiotic regimen 14 days of any active antibiotic treatment for uncomplicated enterococcal bacteremia., 14 days of active antibiotics
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla, Spanish Network for Research in Infectious Diseases, Spanish Clinical Research Network - SCReN
Enterococcal Bacteremia
07/24
12/24
MARIO, NCT05178862 / 2022-000648-32: A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Suspended
3
220
Europe, Canada, US, RoW
SCY-078, Ibrexafungerp, Fluconazole, Diflucan, Echinocandin, Caspofungin, Micafungin, Anidulafungin
Scynexis, Inc., SCYNEXIS, Inc.
Candidiasis, Invasive, Candidemia
06/24
08/24
Marcos, Francisco
INTENSE, NCT05394298: Short vs Long of Usual Treatment for Non Complicated Enterococcal Bacteremia

Recruiting
4
284
Europe
Short-treatment of any active antibiotic regimen 7 days of any active antibiotic treatment for uncomplicated enterococcal bacteremia., 7 days of active antibiotics, Long-treatment of any active antibiotic regimen 14 days of any active antibiotic treatment for uncomplicated enterococcal bacteremia., 14 days of active antibiotics
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla, Spanish Network for Research in Infectious Diseases, Spanish Clinical Research Network - SCReN
Enterococcal Bacteremia
07/24
12/24
ASTARTÉ, NCT04478721: Temocillin vs Meropenem for the Targeted Treatment of Bacteraemia Resistant to Third Gen Cephalosporins

Recruiting
3
334
Europe
Temocillin, Meropenem
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla, Spanish Network for Research in Infectious Diseases, SCReN Spanish research Network- CTU-HUVR
Bacteremia
03/25
12/25
NEW_SAFE, NCT03941951: Study to Optimize the Use of New Antibiotics

Recruiting
N/A
900
Europe
Non-impositive Program for Optimizing the Use of Antimicrobials
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Bacterial Infections, Fungal Infection
12/20
12/22
NCT04801862: Natural History of Clostridioides Difficile Infection

Recruiting
N/A
750
Europe
Hospital Universitario de Valme
Clostridium Difficile Infection, Health Care Associated Infection, Nosocomial Infection
06/24
12/24
Mesa, Belen Gallego
MARIO, NCT05178862 / 2022-000648-32: A Phase 3, Randomized, Double-blind Study for Patients With Invasive Candidiasis Treated With IV Echinocandin Followed by Either Oral Ibrexafungerp or Oral Fluconazole

Suspended
3
220
Europe, Canada, US, RoW
SCY-078, Ibrexafungerp, Fluconazole, Diflucan, Echinocandin, Caspofungin, Micafungin, Anidulafungin
Scynexis, Inc., SCYNEXIS, Inc.
Candidiasis, Invasive, Candidemia
06/24
08/24

Download Options